| __timestamp | ACADIA Pharmaceuticals Inc. | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 68205000 |
| Thursday, January 1, 2015 | 73869000 | 54218000 |
| Friday, January 1, 2016 | 99284000 | 15934000 |
| Sunday, January 1, 2017 | 149189000 | 24390000 |
| Monday, January 1, 2018 | 187163000 | 25389000 |
| Tuesday, January 1, 2019 | 240385000 | 72324000 |
| Wednesday, January 1, 2020 | 319130000 | 184809000 |
| Friday, January 1, 2021 | 239415000 | 205164000 |
| Saturday, January 1, 2022 | 361575000 | 245441000 |
| Sunday, January 1, 2023 | 351619000 | 271823000 |
Cracking the code
In the ever-evolving world of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Madrigal Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc. have demonstrated a steadfast commitment to advancing medical science through substantial R&D investments.
From 2014 to 2023, ACADIA Pharmaceuticals increased its R&D spending by nearly 480%, peaking in 2022. Meanwhile, Madrigal Pharmaceuticals saw a remarkable 300% rise, with its highest expenditure in 2023. This trend underscores the industry's relentless pursuit of groundbreaking therapies.
While ACADIA consistently outspent Madrigal, the latter's rapid growth in R&D investment highlights its strategic focus on innovation. As these companies continue to push the boundaries of medical research, their financial commitment to R&D remains a testament to their dedication to improving global health outcomes.
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Madrigal Pharmaceuticals, Inc.
R&D Insights: How Madrigal Pharmaceuticals, Inc. and ADMA Biologics, Inc. Allocate Funds
Research and Development Investment: Madrigal Pharmaceuticals, Inc. vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Madrigal Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending